TY - JOUR
T1 - Carotid artery stenting in patients with acute coronary syndrome
T2 - A possible primary therapy for symptomatic carotid stenosis
AU - Casana, Renato
AU - Halliday, Alison
AU - Bianchi, Paolo
AU - Fresa, Emanuele
AU - Silani, Vincenzo
AU - Parati, Gianfranco
AU - Blengino, Simonetta
AU - Cireni, Lea
AU - Adobbati, Laura
AU - Calvillo, Laura
AU - Tolva, Valerio S.
PY - 2013/8
Y1 - 2013/8
N2 - Purpose: To report the results of carotid artery stenting (CAS) in symptomatic patients (stroke/transient ischemic attack) after recent percutaneous transluminal coronary angioplasty (PTCA) for acute coronary syndrome (ACS). Methods: Between January 2009 and July 2011, 28 consecutive patients (18 women; mean age 66 years, range 42-82) underwent protected CAS for symptomatic carotid stenosis following recent PTCA that included bare or drug-eluting stents requiring uninterrupted dual antiplatelet therapy. Primary technical success, neurological complications, major adverse cardiovascular events, and death were evaluated at 30 days and over midterm follow-up. Results: Technical success was 96%; 1 patient suffered a nonfatal major stroke (3.5% 30-day stroke rate) during the procedure. During a median 21.6-month follow-up, 4 (14%) patients died of myocardial infarction (all diabetic smokers with ejection fractions 34 kg/m2. Conclusion: This preliminary experience demonstrated that CAS is a reasonable, safe, and effective treatment for patients with symptomatic carotid artery stenosis who were recently treated with coronary stents requiring uninterrupted dual antiplatelet therapy.
AB - Purpose: To report the results of carotid artery stenting (CAS) in symptomatic patients (stroke/transient ischemic attack) after recent percutaneous transluminal coronary angioplasty (PTCA) for acute coronary syndrome (ACS). Methods: Between January 2009 and July 2011, 28 consecutive patients (18 women; mean age 66 years, range 42-82) underwent protected CAS for symptomatic carotid stenosis following recent PTCA that included bare or drug-eluting stents requiring uninterrupted dual antiplatelet therapy. Primary technical success, neurological complications, major adverse cardiovascular events, and death were evaluated at 30 days and over midterm follow-up. Results: Technical success was 96%; 1 patient suffered a nonfatal major stroke (3.5% 30-day stroke rate) during the procedure. During a median 21.6-month follow-up, 4 (14%) patients died of myocardial infarction (all diabetic smokers with ejection fractions 34 kg/m2. Conclusion: This preliminary experience demonstrated that CAS is a reasonable, safe, and effective treatment for patients with symptomatic carotid artery stenosis who were recently treated with coronary stents requiring uninterrupted dual antiplatelet therapy.
KW - Carotid artery stenting
KW - Carotid stenosis
KW - Cerebral protection
KW - Coronary angioplasty
KW - Coronary artery disease
KW - Myocardial infarction
KW - Percutaneous coronary intervention
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=84881504569&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84881504569&partnerID=8YFLogxK
U2 - 10.1583/13-4244.1
DO - 10.1583/13-4244.1
M3 - Article
C2 - 23914865
AN - SCOPUS:84881504569
VL - 20
SP - 546
EP - 551
JO - Journal of Endovascular Therapy
JF - Journal of Endovascular Therapy
SN - 1526-6028
IS - 4
ER -